Debiotech is proud to announce that its product novel syringe-less injector for CT Contrast Media injection “CT Exprés III™”, developed for Swiss Medical Care, has received a clearance from FDA on December 26, 2006.
The CT Exprés III™ is a result of latest innovation in Contrast Media delivery, offering a continuous delivery system of Contrast Media for multiple consecutive patients. The CT Exprés III™ is equipped with two bottles of up to 500 ml of Contrast Media each, plus one Saline bag of up to 3 litres to perform injection on multiple patients without need for unnecessary preparation time and concern about available volume. The CT Exprés III™ is the only “syringe less” injector available in the US, with multi-dose capability.
The CT Exprés III™ is conceived to simplify most of the manipulations needed for each patient, while addressing important safety and aseptic requirements through a novel High Performance disposable Patient Cassette system. The CT Exprés III™ is intended to be compatible with all brands of Contrast Media for CT examinations.
“The CT Exprés III™ is the ultimate response to growing needs in the CT market arena for safety, cost savings and time efficiency. By adding a large Saline bag to the already existing two Contrast Media bottles, the CT examination can be done without unnecessary preparation time and without any practical limitation linked to available Contrast Media or Saline volume. This makes the CT Exprés III™ the first “syringe-less” system available in the US to satisfy CT examination conditions while decreasing the manipulation time in-between patients, hence increasing the potential throughput in a day operation of a CT” says Frédéric Neftel, President of Swiss Medical Care. “We are extremely proud of bringing such a unique product to the US market and contribute to the image of Excellence and Quality which has always been at the heart of Swiss Products”.
The CT Exprés received the Swiss Technology Award in 2005 in recognition for the highly innovative technology offered by the CT Exprés product developed in Switzerland and commercialized worldwide by Swiss Medical Care.
“The market response to the CT Exprés III™, in certain markets where it has been introduced in Europe, has already been outstanding. It corresponds to the most appropriate response for each CT Centre where manipulation time is critical and where professional teams want to delegate more time to the patient while enhancing standards in aseptic manipulation conditions” says Hervé Duffour, Marketing and Sales, Swiss Medical Care.
About CT Exprés III™:
CT Exprés III™ is adding a novel third line to the injector to perform Saline flush directly from a bag in addition to the two up to 500ml Contrast Media bottles. In addition, the CT Exprés III™ offers multiple programming capabilities, for CT procedures, making the best use of Saline procedure before, during and after each Contrast Media phase.
About SMC – Swiss Medical Care:
Swiss Medical Care SA (SMC) was founded by Debiotech SA and a Group of Private Investors to create a company specialising in sales and marketing of innovative products in the field of Diagnostic Imaging. Swiss Medical Care’s product portfolio: "CT Exprés™ " is the result of over 6 years of development targeted at better satisfying customer’s needs, cost containment considerations and safety concerns.